about-us.jpg

ESPE Working Group on Paediatric and Adolescent Gynaecology

The paediatric & adolescent gynaecology working group aims to improve the reproductive health of adolescent girls by bringing together clinical physicians and basic scientists involved and/or interested in the field.

The paediatric & adolescent gynaecology working group aims to improve the reproductive health of adolescent girls by bringing together clinical physicians and basic scientists involved and/or interested in the field.

 


The Annual Meeting Symposium for the PAG Working Group was held online during the virtual ESPE meeting (September 22-26, 2021).

Report on activities from 2020

  • The 2021 PAG Working Group Symposium had an online format, two speakers and a duration of one hour.

The first presentation was from Ana Claudia Latronico (Sao Paulo, Brazil) entitled: Genetics of precocious puberty. The second presentation was from Rikke Beck Jensen (Copenhagen, Denmark), entitled: Early/normal puberty: is any investigation appropriate? The session was well received and had a significant number (around 600) of views.

  • The coordinator of the PAG WG (Lourdes Ibáñez) participated in the 15th European Congress of Paediatric and Adolescent Gynaecology in a first collaboration with a wide organisation devoted to Adolescent Gynaecology. The meeting was postponed to June 2021 due to the COVID pandemic and performed online (https://www.eurapag2021.eu/programme).

 

  • Three members of the PAG WG (Thomas Reinehr, Abel López-Bermejo, and Lourdes Ibáñez), and a former member of the PAG WG (Feyza Darendeliler, Istanbul, Turkey), are among the partners participating in a funded Horizon 2020 project (European Commission), entitled: “PCOS in Adolescent Girls and Young Women: Toward a Treatment Guided by Pathophysiology”. The project will have a duration of 5 years, will be coordinated by Lourdes Ibáñez from Barcelona, and co-coordinated by Francis de Zegher from Belgium; is composed of 17 partners (among them, 7 clinical sites for recruitment of patients), and aims at demonstrating (in a Phase II, randomised, double-blind, placebo-controlled clinical trial) the beneficial effects of a low-dose combination of two insulin sensitisers and one anti-androgen for the treatment of PCOS in adolescent girls and young adult women (AYAs).

This is an extremely important project because PCOS is a very prevalent disorder worldwide and so far, has no approved treatment. The kick-off was on April 1, 2021, and the recruitment of patients started on April 1, 2022.

 

For further information on the activities of this Working Group please contact Lourdes Ibáñez at lourdes.ibanez@sjd.es

 

Working Group Steering Committee

Coordinator

Lourdes Ibáñez

(Spain)

Secretary

Anne-Simone Parent

(Belgium)

Abel López-Bermejo

(Spain)

Thomas Reinehr

(Germany)

Ken Ong

(UK)

Marco Cappa

(Italy)

Rikke Beck Jensen

(Denmark)

Michel Polak

(France)